BETA
Home MEPs Dossiers Committees Subjects Blog About Dumps
download json


2013/0021(NLE) Subjecting 4-methylamphetamine to control measures

Progress: Procedure completed

RoleCommitteeRapporteurShadows
Lead LIBE BONI Michał (icon: PPE PPE)
Committee Opinion ENVI
Lead committee dossier:
Legal Basis:
EC Treaty (after Amsterdam) EC 039

Events

2015/10/20
   Final act published in Official Journal
Details

PURPOSE: to subject 4-methylamphetamine to control measures.

NON-LEGISLATIVE ACT: Council Implementing Decision (EU) 2015/1874 on subjecting 4-methylamphetamine to control measures.

CONTENT: the Council adopted an implementing decision on subjecting 4-methylamphetamine to control measures across the Union.

4-methylamphetamine is a synthetic ring-methylated derivative of amphetamine. It has emerged on the illicit amphetamine market where it is sold and used as the controlled drug, amphetamine.

Decision 2005/387/JHA confers upon the Council implementing powers with a view to giving a quick and expertise-based response at Union level to the emergence of new psychoactive substances detected and reported by the Member States, by subjecting those substances to control measures across the Union.

A risk assessment report on 4-methylamphetamine was drawn up in accordance with Decision 2005/387/JHA by a special session of the extended Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

The report revealed that there is limited scientific evidence available on the characteristics and risks of 4-methylamphetamine and points out that further studies are required on the overall health and social risks associated with the substance. However, the evidence available provides sufficient grounds for subjecting 4-methylamphetamine to control measures across the Union.

Decision 2013/129/EU ceases to produce effects as of the day of entry into force of this Decision, without prejudice to the obligations of the Member States relating to the time limit for subjecting that new psychoactive substance to control measures and criminal penalties in their national laws.

ENTRY INTO FORCE: 21.10.2015.

Documents
Decision 2015/1874
OJ L 275 20.10.2015, p. 0035
2015/10/08
   EP/CSL - Act adopted by Council after consultation of Parliament
2015/10/08
   EP - End of procedure in Parliament
2015/10/06
   EP - Results of vote in Parliament
Documents
Results of vote in Parliament
2015/10/06
   EP - Decision by Parliament
Details

The European Parliament adopted by 649 votes to 6, with 34 abstentions, a legislative resolution on the draft Council implementing decision on subjecting 4-methylamphetamine to control measures.

In line with the Committee on Civil Liberties, Justice and Home Affairs, the European Parliament approved the Council draft aiming to subject 4-methylamphetamine to control measures.

Documents
T8-0326/2015
2015/09/28
   EP - Committee report tabled for plenary, 1st reading/single reading
Details

The Committee on Civil Liberties, Justice and Home Affairs adopted the report by Michał BONI (EPP, PL) on the draft Council implementing decision on subjecting 4methylamphetamine to control measures.

The committee approved the Council draft which seeks to invite the Member States to subject the new psychoactive substance 4-methylamphetamine to control measures across the Union.

In compliance with Council Decision 2005/387/JHA on the information exchange, risk-assessment and control of new psychoactive substances, the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) assessed the risks on the new psychoactive substance 4-methylamphetamine . The risk assessment report was subsequently submitted to the Commission and to the Council on 29 November 2012.

Documents
A8-0265/2015
2015/09/22
   EP - Vote in committee
2015/09/03
   EP - BONI Michał (PPE) appointed as rapporteur in LIBE
2015/09/01
   EP - Committee draft report
Documents
PE564.978
2015/07/09
   EP - Committee referral announced in Parliament
2015/06/30
   CSL - Legislative proposal
Details

PURPOSE: to subject 4-methylamphetamine to control measures.

PROPOSED ACT: Implementing Council Decision.

ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

BACKGROUND: in compliance with Council Decision 2005/387/JHA on the information exchange, risk-assessment and control of new psychoactive substances, the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) assessed the risks on the new psychoactive substance 4-methylamphetamine . The risk assessment report was subsequently submitted to the Commission and to the Council on 29 November 2012.

4-methylamphetamine is a synthetic ring-methylated derivative of amphetamine. It has emerged on the illicit amphetamine market where it is sold and used as the controlled drug, amphetamine.

There has been one report of the substance being detected in a commercial product sold on the internet.

According to the limited data sources available, the acute toxicity of 4-methylamphetamine is similar to that of other stimulants. There have been a total of 21 fatalities registered in four Member States where 4-methylamphetamine alone, or in combination with one or more substances, especially amphetamine, has been detected in post-mortem samples.

4-methylamphetamine has been detected in 15 Member States, while one Member State has reported the manufacture of the substance on its territory. Eight Member States control the substance under drug control legislation. The information available suggests that 4-methylamphetamine is produced and distributed by the same organised crime groups that are involved in the manufacture and trafficking of amphetamine.

The Risk Assessment Report reveals that there is limited scientific evidence available on the characteristics and risks of 4-methylamphetamine and points out that further studies are required on the overall health and social risks associated with the substance.

However, the evidence available provides sufficient grounds for subjecting 4-methylamphetamine to control measures across the Union. As a result of the health risks it poses, as documented by its detection in several reported fatalities, especially when used in combination with other substances, of its strong resemblance in terms of appearance and effects with amphetamine, of the fact that users may unknowingly consume the substance, and of its limited medical value or use, 4-methylamphetamine should be subjected to control measures across the Union.

CONTENT: this proposal aims to invite the Member States to subject the new psychoactive substance 4-methylamphetamine to control measures across the Union .

Decision 2013/129/EU ceases to produce effects from the date of entry into force of this Decision, without prejudice to the obligations of the Member States relating to the time limit for subjecting 4-methylamphetamine to control measures and criminal penalties in their national laws.

The United Kingdom shall not take part in the adoption of this Decision and is not bound by it or subject to its application.

Documents
10010/2015
2015/06/29
   EC - Legislative proposal published
Details

PURPOSE: to subject 4-methylamphetamine to control measures.

PROPOSED ACT: Implementing Council Decision.

ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

BACKGROUND: in compliance with Council Decision 2005/387/JHA on the information exchange, risk-assessment and control of new psychoactive substances, the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) assessed the risks on the new psychoactive substance 4-methylamphetamine . The risk assessment report was subsequently submitted to the Commission and to the Council on 29 November 2012.

4-methylamphetamine is a synthetic ring-methylated derivative of amphetamine. It has emerged on the illicit amphetamine market where it is sold and used as the controlled drug, amphetamine.

There has been one report of the substance being detected in a commercial product sold on the internet.

According to the limited data sources available, the acute toxicity of 4-methylamphetamine is similar to that of other stimulants. There have been a total of 21 fatalities registered in four Member States where 4-methylamphetamine alone, or in combination with one or more substances, especially amphetamine, has been detected in post-mortem samples.

4-methylamphetamine has been detected in 15 Member States, while one Member State has reported the manufacture of the substance on its territory. Eight Member States control the substance under drug control legislation. The information available suggests that 4-methylamphetamine is produced and distributed by the same organised crime groups that are involved in the manufacture and trafficking of amphetamine.

The Risk Assessment Report reveals that there is limited scientific evidence available on the characteristics and risks of 4-methylamphetamine and points out that further studies are required on the overall health and social risks associated with the substance.

However, the evidence available provides sufficient grounds for subjecting 4-methylamphetamine to control measures across the Union. As a result of the health risks it poses, as documented by its detection in several reported fatalities, especially when used in combination with other substances, of its strong resemblance in terms of appearance and effects with amphetamine, of the fact that users may unknowingly consume the substance, and of its limited medical value or use, 4-methylamphetamine should be subjected to control measures across the Union.

CONTENT: this proposal aims to invite the Member States to subject the new psychoactive substance 4-methylamphetamine to control measures across the Union .

Decision 2013/129/EU ceases to produce effects from the date of entry into force of this Decision, without prejudice to the obligations of the Member States relating to the time limit for subjecting 4-methylamphetamine to control measures and criminal penalties in their national laws.

The United Kingdom shall not take part in the adoption of this Decision and is not bound by it or subject to its application.

Documents
10010/2015

Documents

Activities

Votes

A8-0265/2015 - Michał Boni - Vote unique #

2015/10/06 Outcome: +: 649, 0: 34, -: 6
DE FR IT ES PL RO GB CZ BE SE EL HU AT NL PT BG FI HR DK SK LT IE LV SI MT EE CY LU
Total
88
72
69
49
47
30
58
21
19
19
19
19
18
25
17
16
12
11
11
12
10
10
8
8
6
5
5
4
icon: PPE PPE
200

Germany PPE

29

France PPE

19

Italy PPE

14

Spain PPE

14

Poland PPE

23

Romania PPE

13

Czechia PPE

7

Belgium PPE

3

Sweden PPE

4

Greece PPE

5

Hungary PPE

10

Austria PPE

5

Netherlands PPE

5

Portugal PPE

5

Bulgaria PPE

7

Finland PPE

3

Croatia PPE

5

Denmark PPE

For (1)

Bendt BENDTSEN
1

Slovakia PPE

5

Lithuania PPE

2

Ireland PPE

4

Latvia PPE

4

Slovenia PPE

5

Malta PPE

3

Estonia PPE

For (1)

Tunne KELAM
1

Cyprus PPE

2

Luxembourg PPE

2
icon: S&D S&D
180

Germany S&D

26

France S&D

13

Italy S&D

28

Spain S&D

13

Poland S&D

4

Romania S&D

14

United Kingdom S&D

21

Czechia S&D

4

Belgium S&D

4

Sweden S&D

5

Greece S&D

3

Hungary S&D

4

Austria S&D

5

Netherlands S&D

2

Portugal S&D

8

Bulgaria S&D

4

Finland S&D

2

Croatia S&D

2

Denmark S&D

3

Slovakia S&D

4

Lithuania S&D

2

Ireland S&D

For (1)

Nessa CHILDERS
1

Latvia S&D

1

Slovenia S&D

For (1)

Tanja FAJON
1

Malta S&D

3

Estonia S&D

For (1)

Marju LAURISTIN
1

Cyprus S&D

1

Luxembourg S&D

For (1)

Mady DELVAUX
1
icon: ALDE ALDE
63

Germany ALDE

3

France ALDE

7

Spain ALDE

8

Romania ALDE

2

Czechia ALDE

4

Belgium ALDE

6

Sweden ALDE

3

Austria ALDE

For (1)

Angelika MLINAR
1

Netherlands ALDE

7

Portugal ALDE

2

Bulgaria ALDE

4

Finland ALDE

4

Croatia ALDE

2

Denmark ALDE

2

Lithuania ALDE

3

Ireland ALDE

For (1)

Marian HARKIN
1

Latvia ALDE

1

Slovenia ALDE

For (1)

Ivo VAJGL
1

Estonia ALDE

2
icon: Verts/ALE Verts/ALE
48

Germany Verts/ALE

12

France Verts/ALE

6

Spain Verts/ALE

4

United Kingdom Verts/ALE

5

Belgium Verts/ALE

2

Sweden Verts/ALE

4

Hungary Verts/ALE

2

Austria Verts/ALE

3

Netherlands Verts/ALE

2

Finland Verts/ALE

For (1)

Heidi HAUTALA
1

Croatia Verts/ALE

For (1)

Davor ŠKRLEC
1

Denmark Verts/ALE

For (1)

Margrete AUKEN
1

Lithuania Verts/ALE

For (1)

Bronis ROPĖ
1

Latvia Verts/ALE

1

Slovenia Verts/ALE

For (1)

Igor ŠOLTES
1

Estonia Verts/ALE

For (1)

Indrek TARAND
1

Luxembourg Verts/ALE

For (1)

Claude TURMES
1
icon: GUE/NGL GUE/NGL
48

Germany GUE/NGL

8

France GUE/NGL

4

Italy GUE/NGL

3

Spain GUE/NGL

10

United Kingdom GUE/NGL

1

Czechia GUE/NGL

3

Sweden GUE/NGL

For (1)

Malin BJÖRK
1

Greece GUE/NGL

5

Netherlands GUE/NGL

3

Portugal GUE/NGL

2

Finland GUE/NGL

For (1)

Merja KYLLÖNEN
1

Denmark GUE/NGL

For (1)

Rina Ronja KARI
1

Ireland GUE/NGL

Abstain (1)

Luke Ming FLANAGAN
4

Cyprus GUE/NGL

2
icon: ECR ECR
56

Germany ECR

8

Italy ECR

2

Poland ECR

18

United Kingdom ECR

9

Czechia ECR

2

Belgium ECR

3

Greece ECR

For (1)

Notis MARIAS
1

Netherlands ECR

2

Bulgaria ECR

1

Finland ECR

For (1)

Jussi HALLA-AHO
1

Croatia ECR

For (1)

Ruža TOMAŠIĆ
1

Denmark ECR

3

Slovakia ECR

Abstain (1)

Richard SULÍK
3

Lithuania ECR

1

Latvia ECR

For (1)

Roberts ZĪLE
1
icon: ENF ENF
38

France ENF

21

Italy ENF

5

Poland ENF

For (1)

Michał MARUSIK
1

Romania ENF

1

United Kingdom ENF

Abstain (1)

Janice ATKINSON
1

Belgium ENF

For (1)

Gerolf ANNEMANS
1

Austria ENF

4

Netherlands ENF

4
icon: EFDD EFDD
43

France EFDD

1

Italy EFDD

17

Poland EFDD

1

United Kingdom EFDD

20

Czechia EFDD

Against (1)

Petr MACH
1

Sweden EFDD

2

Lithuania EFDD

For (1)

Rolandas PAKSAS
1
icon: NI NI
12

Germany NI

For (1)

Udo VOIGT

Against (1)

Martin SONNEBORN
2

France NI

For (1)

Bruno GOLLNISCH
1

United Kingdom NI

For (1)

Diane DODDS
1

Greece NI

5

Hungary NI

3

History

(these mark the time of scraping, not the official date of the change)

2023-08-03Show (2) Changes | Timetravel
docs/0
date
2015-06-30T00:00:00
docs
url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=10010%2F15&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC title: 10010/2015
summary
type
Legislative proposal
body
CSL
events/0/date
Old
2015-06-30T00:00:00
New
2015-06-29T00:00:00
2021-12-18Show (8) Changes | Timetravel
docs/0/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE564.978
New
https://www.europarl.europa.eu/doceo/document/LIBE-PR-564978_EN.html
events/1/type
Old
Committee referral announced in Parliament, 1st reading/single reading
New
Committee referral announced in Parliament
events/2/type
Old
Vote in committee, 1st reading/single reading
New
Vote in committee
events/3/docs/0/url
Old
http://www.europarl.europa.eu/doceo/document/A-8-2015-0265_EN.html
New
https://www.europarl.europa.eu/doceo/document/A-8-2015-0265_EN.html
events/5
date
2015-10-06T00:00:00
type
Decision by Parliament
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/TA-8-2015-0326_EN.html title: T8-0326/2015
summary
events/5
date
2015-10-06T00:00:00
type
Decision by Parliament, 1st reading/single reading
body
EP
docs
url: http://www.europarl.europa.eu/doceo/document/TA-8-2015-0326_EN.html title: T8-0326/2015
summary
procedure/Modified legal basis
Rules of Procedure EP 159
procedure/Other legal basis
Rules of Procedure EP 159
2020-01-19Show (4) Changes | Timetravel
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
rapporteur
name: BONI Michał date: 2015-09-03T00:00:00 group: European People's Party (Christian Democrats) abbr: PPE
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
date
2015-09-03T00:00:00
rapporteur
name: BONI Michał group: European People's Party (Christian Democrats) abbr: PPE
events/3/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2015-0265&language=EN
New
http://www.europarl.europa.eu/doceo/document/A-8-2015-0265_EN.html
events/5/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2015-0326
New
http://www.europarl.europa.eu/doceo/document/TA-8-2015-0326_EN.html
2019-07-06Show (17) Changes | Timetravel
activities
  • date: 2015-06-30T00:00:00 docs: url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=10010%2F15&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC type: Legislative proposal published title: 10010/2015 body: EC commission: DG: url: http://ec.europa.eu/justice/ title: Justice Commissioner: JOUROVÁ Věra type: Legislative proposal published
  • date: 2015-07-09T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI body: EP responsible: True committee: LIBE date: 2015-09-03T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: EPP name: BONI Michał
  • date: 2015-09-22T00:00:00 body: EP type: Vote in committee, 1st reading/single reading committees: body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI body: EP responsible: True committee: LIBE date: 2015-09-03T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: EPP name: BONI Michał
  • body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2015-0265&language=EN type: Committee report tabled for plenary, 1st reading/single reading title: A8-0265/2015 type: Committee report tabled for plenary, 1st reading/single reading committees: body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI body: EP responsible: True committee: LIBE date: 2015-09-03T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: EPP name: BONI Michał date: 2015-09-28T00:00:00
  • date: 2015-10-06T00:00:00 docs: url: http://www.europarl.europa.eu/oeil/popups/sda.do?id=26166&l=en type: Results of vote in Parliament title: Results of vote in Parliament url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2015-0326 type: Decision by Parliament, 1st reading/single reading title: T8-0326/2015 body: EP type: Results of vote in Parliament
  • date: 2015-10-08T00:00:00 body: EP/CSL type: Act adopted by Council after consultation of Parliament
  • date: 2015-10-20T00:00:00 docs: url: http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32015D1874 title: Decision 2015/1874 url: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2015:275:TOC title: OJ L 275 20.10.2015, p. 0035 type: Final act published in Official Journal
commission
  • body: EC dg: Justice and Consumers commissioner: JOUROVÁ Věra
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
date
2015-09-03T00:00:00
rapporteur
name: BONI Michał group: European People's Party (Christian Democrats) abbr: PPE
committees/0
body
EP
responsible
False
committee_full
Environment, Public Health and Food Safety
committee
ENVI
committees/1
type
Committee Opinion
body
EP
associated
False
committee_full
Environment, Public Health and Food Safety
committee
ENVI
opinion
False
committees/1
body
EP
responsible
True
committee
LIBE
date
2015-09-03T00:00:00
committee_full
Civil Liberties, Justice and Home Affairs
rapporteur
group: EPP name: BONI Michał
docs
  • date: 2015-09-01T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE564.978 title: PE564.978 type: Committee draft report body: EP
events
  • date: 2015-06-30T00:00:00 type: Legislative proposal published body: EC docs: url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=10010%2F15&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC title: 10010/2015 summary: PURPOSE: to subject 4-methylamphetamine to control measures. PROPOSED ACT: Implementing Council Decision. ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion. BACKGROUND: in compliance with Council Decision 2005/387/JHA on the information exchange, risk-assessment and control of new psychoactive substances, the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) assessed the risks on the new psychoactive substance 4-methylamphetamine . The risk assessment report was subsequently submitted to the Commission and to the Council on 29 November 2012. 4-methylamphetamine is a synthetic ring-methylated derivative of amphetamine. It has emerged on the illicit amphetamine market where it is sold and used as the controlled drug, amphetamine. There has been one report of the substance being detected in a commercial product sold on the internet. According to the limited data sources available, the acute toxicity of 4-methylamphetamine is similar to that of other stimulants. There have been a total of 21 fatalities registered in four Member States where 4-methylamphetamine alone, or in combination with one or more substances, especially amphetamine, has been detected in post-mortem samples. 4-methylamphetamine has been detected in 15 Member States, while one Member State has reported the manufacture of the substance on its territory. Eight Member States control the substance under drug control legislation. The information available suggests that 4-methylamphetamine is produced and distributed by the same organised crime groups that are involved in the manufacture and trafficking of amphetamine. The Risk Assessment Report reveals that there is limited scientific evidence available on the characteristics and risks of 4-methylamphetamine and points out that further studies are required on the overall health and social risks associated with the substance. However, the evidence available provides sufficient grounds for subjecting 4-methylamphetamine to control measures across the Union. As a result of the health risks it poses, as documented by its detection in several reported fatalities, especially when used in combination with other substances, of its strong resemblance in terms of appearance and effects with amphetamine, of the fact that users may unknowingly consume the substance, and of its limited medical value or use, 4-methylamphetamine should be subjected to control measures across the Union. CONTENT: this proposal aims to invite the Member States to subject the new psychoactive substance 4-methylamphetamine to control measures across the Union . Decision 2013/129/EU ceases to produce effects from the date of entry into force of this Decision, without prejudice to the obligations of the Member States relating to the time limit for subjecting 4-methylamphetamine to control measures and criminal penalties in their national laws. The United Kingdom shall not take part in the adoption of this Decision and is not bound by it or subject to its application.
  • date: 2015-07-09T00:00:00 type: Committee referral announced in Parliament, 1st reading/single reading body: EP
  • date: 2015-09-22T00:00:00 type: Vote in committee, 1st reading/single reading body: EP
  • date: 2015-09-28T00:00:00 type: Committee report tabled for plenary, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2015-0265&language=EN title: A8-0265/2015 summary: The Committee on Civil Liberties, Justice and Home Affairs adopted the report by Michał BONI (EPP, PL) on the draft Council implementing decision on subjecting 4methylamphetamine to control measures. The committee approved the Council draft which seeks to invite the Member States to subject the new psychoactive substance 4-methylamphetamine to control measures across the Union. In compliance with Council Decision 2005/387/JHA on the information exchange, risk-assessment and control of new psychoactive substances, the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) assessed the risks on the new psychoactive substance 4-methylamphetamine . The risk assessment report was subsequently submitted to the Commission and to the Council on 29 November 2012.
  • date: 2015-10-06T00:00:00 type: Results of vote in Parliament body: EP docs: url: https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=26166&l=en title: Results of vote in Parliament
  • date: 2015-10-06T00:00:00 type: Decision by Parliament, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2015-0326 title: T8-0326/2015 summary: The European Parliament adopted by 649 votes to 6, with 34 abstentions, a legislative resolution on the draft Council implementing decision on subjecting 4-methylamphetamine to control measures. In line with the Committee on Civil Liberties, Justice and Home Affairs, the European Parliament approved the Council draft aiming to subject 4-methylamphetamine to control measures.
  • date: 2015-10-08T00:00:00 type: Act adopted by Council after consultation of Parliament body: EP/CSL
  • date: 2015-10-08T00:00:00 type: End of procedure in Parliament body: EP
  • date: 2015-10-20T00:00:00 type: Final act published in Official Journal summary: PURPOSE: to subject 4-methylamphetamine to control measures. NON-LEGISLATIVE ACT: Council Implementing Decision (EU) 2015/1874 on subjecting 4-methylamphetamine to control measures. CONTENT: the Council adopted an implementing decision on subjecting 4-methylamphetamine to control measures across the Union. 4-methylamphetamine is a synthetic ring-methylated derivative of amphetamine. It has emerged on the illicit amphetamine market where it is sold and used as the controlled drug, amphetamine. Decision 2005/387/JHA confers upon the Council implementing powers with a view to giving a quick and expertise-based response at Union level to the emergence of new psychoactive substances detected and reported by the Member States, by subjecting those substances to control measures across the Union. A risk assessment report on 4-methylamphetamine was drawn up in accordance with Decision 2005/387/JHA by a special session of the extended Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The report revealed that there is limited scientific evidence available on the characteristics and risks of 4-methylamphetamine and points out that further studies are required on the overall health and social risks associated with the substance. However, the evidence available provides sufficient grounds for subjecting 4-methylamphetamine to control measures across the Union. Decision 2013/129/EU ceases to produce effects as of the day of entry into force of this Decision, without prejudice to the obligations of the Member States relating to the time limit for subjecting that new psychoactive substance to control measures and criminal penalties in their national laws. ENTRY INTO FORCE: 21.10.2015. docs: title: Decision 2015/1874 url: https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32015D1874 title: OJ L 275 20.10.2015, p. 0035 url: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2015:275:TOC
links
other
  • body: EC dg: url: http://ec.europa.eu/justice/ title: Justice commissioner: JOUROVÁ Věra
procedure/Modified legal basis
Old
Rules of Procedure of the European Parliament EP 150
New
Rules of Procedure EP 159
procedure/dossier_of_the_committee
Old
LIBE/8/03853
New
  • LIBE/8/03853
procedure/final/url
Old
http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32015D1874
New
https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32015D1874
procedure/subject
Old
  • 7.30.30.04 Action to combat drugs and drug-trafficking
New
7.30.30.04
Action to combat drugs and drug-trafficking
procedure/subtype
Old
Consultation of Parliament
New
  • Consultation of Parliament
  • See also Decision 2005/387/JHA 2003/0215(CNS)
procedure/summary
  • See also Decision 2005/387/JHA
procedure/title
Old
Implementing decision on subjecting 4-methylamphetamine to control measures
New
Subjecting 4-methylamphetamine to control measures
2016-07-06Show (4) Changes | Timetravel
activities/5
date
2015-10-08T00:00:00
body
EP/CSL
type
Act adopted by Council after consultation of Parliament
activities/6
date
2015-10-20T00:00:00
docs
type
Final act published in Official Journal
procedure/final
url
http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!CELEXnumdoc&lg=EN&numdoc=32015D1874
title
Decision 2015/1874
procedure/stage_reached
Old
Awaiting final decision
New
Procedure completed
2016-02-11Show (2) Changes | Timetravel
activities/4/docs/0
url
http://www.europarl.europa.eu/oeil/popups/sda.do?id=26166&l=en
type
Results of vote in Parliament
title
Results of vote in Parliament
activities/4/type
Old
Decision by Parliament, 1st reading/single reading
New
Results of vote in Parliament
2015-10-21Show (11) Changes | Timetravel
activities/0/commission/0
DG
Commissioner
JOUROVÁ Věra
activities/1/committees/1/date
2015-09-03T00:00:00
activities/1/committees/1/rapporteur
  • group: EPP name: BONI Michał
activities/2
date
2015-09-22T00:00:00
body
EP
type
Vote in committee, 1st reading/single reading
committees
activities/3
body
EP
docs
url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2015-0265&language=EN type: Committee report tabled for plenary, 1st reading/single reading title: A8-0265/2015
type
Committee report tabled for plenary, 1st reading/single reading
committees
date
2015-09-28T00:00:00
activities/4
date
2015-10-06T00:00:00
docs
url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2015-0326 type: Decision by Parliament, 1st reading/single reading title: T8-0326/2015
body
EP
type
Decision by Parliament, 1st reading/single reading
committees/1/date
2015-09-03T00:00:00
committees/1/rapporteur
  • group: EPP name: BONI Michał
other/0
body
EC
dg
commissioner
JOUROVÁ Věra
procedure/Modified legal basis
Rules of Procedure of the European Parliament EP 150
procedure/stage_reached
Old
Awaiting committee decision
New
Awaiting final decision
2015-07-31Show (1) Changes | Timetravel
activities/0/docs/0/text

  • PURPOSE: to subject 4-methylamphetamine to control measures.

    PROPOSED ACT: Implementing Council Decision.

    ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.

    BACKGROUND: in compliance with Council Decision 2005/387/JHA on the information exchange, risk-assessment and control of new psychoactive substances, the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) assessed the risks on the new psychoactive substance 4-methylamphetamine. The risk assessment report was subsequently submitted to the Commission and to the Council on 29 November 2012.

    4-methylamphetamine is a synthetic ring-methylated derivative of amphetamine. It has emerged on the illicit amphetamine market where it is sold and used as the controlled drug, amphetamine.

    There has been one report of the substance being detected in a commercial product sold on the internet.

    According to the limited data sources available, the acute toxicity of 4-methylamphetamine is similar to that of other stimulants. There have been a total of 21 fatalities registered in four Member States where 4-methylamphetamine alone, or in combination with one or more substances, especially amphetamine, has been detected in post-mortem samples.

    4-methylamphetamine has been detected in 15 Member States, while one Member State has reported the manufacture of the substance on its territory. Eight Member States control the substance under drug control legislation. The information available suggests that 4-methylamphetamine is produced and distributed by the same organised crime groups that are involved in the manufacture and trafficking of amphetamine.

    The Risk Assessment Report reveals that there is limited scientific evidence available on the characteristics and risks of 4-methylamphetamine and points out that further studies are required on the overall health and social risks associated with the substance.

    However, the evidence available provides sufficient grounds for subjecting 4-methylamphetamine to control measures across the Union. As a result of the health risks it poses, as documented by its detection in several reported fatalities, especially when used in combination with other substances, of its strong resemblance in terms of appearance and effects with amphetamine, of the fact that users may unknowingly consume the substance, and of its limited medical value or use, 4-methylamphetamine should be subjected to control measures across the Union.

    CONTENT: this proposal aims to invite the Member States to subject the new psychoactive substance 4-methylamphetamine to control measures across the Union.

    Decision 2013/129/EU ceases to produce effects from the date of entry into force of this Decision, without prejudice to the obligations of the Member States relating to the time limit for subjecting 4-methylamphetamine to control measures and criminal penalties in their national laws.

    The United Kingdom shall not take part in the adoption of this Decision and is not bound by it or subject to its application.
2015-07-15Show (5) Changes
activities
  • date: 2015-06-30T00:00:00 docs: url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=ADV&RESULTSET=1&DOC_ID=10010%2F15&DOC_LANCD=EN&ROWSPP=25&NRROWS=500&ORDERBY=DOC_DATE+DESC type: Legislative proposal published title: 10010/2015 type: Legislative proposal published body: EC commission:
  • date: 2015-07-09T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI body: EP responsible: True committee_full: Civil Liberties, Justice and Home Affairs committee: LIBE
committees
  • body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI
  • body: EP responsible: True committee_full: Civil Liberties, Justice and Home Affairs committee: LIBE
links
other
    procedure
    dossier_of_the_committee
    LIBE/8/03853
    reference
    2013/0021(NLE)
    title
    Implementing decision on subjecting 4-methylamphetamine to control measures
    legal_basis
    EC Treaty (after Amsterdam) EC 039
    stage_reached
    Awaiting committee decision
    summary
    See also Decision 2005/387/JHA
    subtype
    Consultation of Parliament
    type
    NLE - Non-legislative enactments
    subject
    7.30.30.04 Action to combat drugs and drug-trafficking
    @parltrack
    @parltrack@eupolicy.social
    [javascript protected email address]
    code AGPLv3.0+
    data ODBLv1.0
    site content CC-By-Sa-3.0

    ParlTrack - 2011-2024

    © European Union, 2011 – Source: European Parliament
    Hosted by AS250.net Foundation